{"id":469891,"date":"2010-03-24T18:42:00","date_gmt":"2010-03-24T22:42:00","guid":{"rendered":"http:\/\/techdirt.com\/articles\/20100323\/0338018672.shtml"},"modified":"2010-03-24T18:42:00","modified_gmt":"2010-03-24T22:42:00","slug":"pay-for-delay-ban-dropped-from-health-care-reform","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/469891","title":{"rendered":"Pay-For-Delay Ban Dropped From Health Care Reform"},"content":{"rendered":"<p>While plenty of folks are still digging through what the new health care reform (really medical insurance reform) law <i>really<\/i> means (and it&#8217;s likely not what you hear most of the TV pundits talking about), it&#8217;s unfortunate to hear that <a href=\"http:\/\/legaltimes.typepad.com\/blt\/2010\/03\/ban-on-pay-for-delay-patent-settlements-cut-from-health-care-bill.html\" >the provision to ban &#8220;pay for delay&#8221; schemes from pharma companies was removed<\/a>.  We talked about these <a href=\"http:\/\/www.techdirt.com\/articles\/20091204\/0026397198.shtml\">sneaky deals<\/a> last year.  Basically, big pharma companies threaten (and often sue) the makers of generic drugs, just before a drug is about to go off patent.  There is no actual patent infringement as the basis of the lawsuit, but the lawsuit acts as a negotiating ploy, with part of the &#8220;settlement&#8221; being an agreement from the generic drug maker <i>not to enter the market<\/i>.  It&#8217;s a blatantly anti-competitive move. Basically, the pharma companies leverage their gov&#8217;t granted monopoly to build up a bunch of cash, which they can then use to pay off potential competitors in order to keep that monopoly for years past the expiration of the patent.<\/p>\n<p>It makes drugs much more expensive for everyone while being a clearly anti-competitive practice.  So it seemed like a good thing that the health care reform bill was supposed to ban it.  Until&#8230; of course&#8230; it was removed days before the bill was approved.  No matter what your take is on health care reform, it&#8217;s hard to see any reason to allow this kind of practice to continue, and even if it wasn&#8217;t included in the the health care reform bill, and isn&#8217;t included in the current patent reform bill, it seems like there&#8217;s no reason the FTC can&#8217;t just step in and make the point that this is blatantly anti-competitive.  The FTC <i>knows<\/i> this is a problem &#8212; and has even said that these sorts of deals have cost US citizens <i>$3.5 billion per year<\/i> in higher drug costs.<\/p>\n<p><a href=\"http:\/\/techdirt.com\/articles\/20100323\/0338018672.shtml\">Permalink<\/a> | <a href=\"http:\/\/techdirt.com\/articles\/20100323\/0338018672.shtml#comments\">Comments<\/a> | <a href=\"http:\/\/techdirt.com\/article.php?sid=20100323\/0338018672&#038;op=sharethis\">Email This Story<\/a><br \/>\n <br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=6c2eaa4ce3b62d2b7360b90b8251d779&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=6c2eaa4ce3b62d2b7360b90b8251d779&#038;p=1\"\/><\/a><br \/>\n<!-- foo --><\/p>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.techdirt.com\/~ff\/techdirt\/feed?a=54k9Jz_m0DA:s0N4qveyyko:D7DqB2pKExk\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/techdirt\/feed?i=54k9Jz_m0DA:s0N4qveyyko:D7DqB2pKExk\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.techdirt.com\/~ff\/techdirt\/feed?a=54k9Jz_m0DA:s0N4qveyyko:c-S6u7MTCTE\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/techdirt\/feed?d=c-S6u7MTCTE\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/techdirt\/feed\/~4\/54k9Jz_m0DA\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>While plenty of folks are still digging through what the new health care reform (really medical insurance reform) law really means (and it&#8217;s likely not what you hear most of the TV pundits talking about), it&#8217;s unfortunate to hear that the provision to ban &#8220;pay for delay&#8221; schemes from pharma companies was removed. We talked [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-469891","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/469891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=469891"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/469891\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=469891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=469891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=469891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}